Applechat Applechat
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Reels
  • Blogs
  • Offres
  • Emplois
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Shradha Pawar Ajouter une nouvelle offre d'emploi Health
    2026-05-05 07:40:02 -
    Ulcerative Colitis Market Growth: Key Drivers and Emerging Opportunities
    The Ulcerative Colitis Market growth is strongly driven by increasing incidence of inflammatory bowel disease across the globe. Lifestyle changes, stress, and unhealthy dietary habits are major contributing factors to the rising patient population. Early diagnosis and better disease awareness have led to increased treatment adoption rates, further boosting market expansion. Hospitals and...
    0 Commentaires 0 Parts 732 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Kajal Khomane Ajouter une nouvelle offre d'emploi Autre
    2026-02-23 10:16:11 -
    Ulcerative Colitis Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
    "Global Executive Summary Ulcerative Colitis Market: Size, Share, and Forecast Data Bridge Market Research analyses that the global ulcerative colitis market which was USD 7,321.78 million in 2023, would rocket up to USD 10,792.98 million by 2030, and is expected to undergo a CAGR of 5.7% during the forecast period. This indicates that the market value. "Multivitamin" dominates the product...
    0 Commentaires 0 Parts 2KB Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Surbhi Verma Ajouter une nouvelle offre d'emploi Health
    2026-08-05 09:50:01 -
    Ulcerative Colitis Market: Are Advanced Biologics Finally Closing the Treatment Gap for Moderate-to-Severe Patients?
    Ulcerative colitis's therapeutic transformation — the shift from conventional aminosalicylates and corticosteroids toward advanced biologics and small-molecule therapies (anti-TNF agents, anti-integrin therapies, JAK inhibitors, and S1P receptor modulators) targeting the underlying inflammatory pathways of this chronic relapsing bowel disease — represents the central commercial...
    0 Commentaires 0 Parts 97 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2026 Applechat French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Contactez nous Annuaire